[
  {
    "ts": "2025-04-03T12:00:00+00:00",
    "headline": "Revvity to Hold Earnings Call on Monday, April 28, 2025",
    "summary": "WALTHAM, Mass., April 03, 2025--Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2025 financial results prior to market open on Monday, April 28, 2025. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.",
    "url": "https://finance.yahoo.com/news/revvity-hold-earnings-call-monday-120000076.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "7ceaaf9d-e906-3922-a926-7cc8cca4f412",
      "content": {
        "id": "7ceaaf9d-e906-3922-a926-7cc8cca4f412",
        "contentType": "STORY",
        "title": "Revvity to Hold Earnings Call on Monday, April 28, 2025",
        "description": "",
        "summary": "WALTHAM, Mass., April 03, 2025--Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2025 financial results prior to market open on Monday, April 28, 2025. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.",
        "pubDate": "2025-04-03T12:00:00Z",
        "displayTime": "2025-04-03T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/330c712b7ff7ded2dd5b43c3dab0ea4c",
          "originalWidth": 784,
          "originalHeight": 320,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U1MI8KHwdCjE7HthTa02Jw--~B/aD0zMjA7dz03ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/330c712b7ff7ded2dd5b43c3dab0ea4c.cf.webp",
              "width": 784,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/24k3x8N6zYRat2RlQ.bnuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/330c712b7ff7ded2dd5b43c3dab0ea4c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revvity-hold-earnings-call-monday-120000076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revvity-hold-earnings-call-monday-120000076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-04-03T09:21:33+00:00",
    "headline": "FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo",
    "summary": "The World Health Organization recognises the test as the “only” enzyme-linked immunospot-based interferon-gamma release assay.",
    "url": "https://www.medicaldevice-network.com/news/fda-revvity-tuberculosis-test/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "f838d2c1-1568-3d51-9a96-acac56227283",
      "content": {
        "id": "f838d2c1-1568-3d51-9a96-acac56227283",
        "contentType": "STORY",
        "title": "FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo",
        "description": "",
        "summary": "The World Health Organization recognises the test as the “only” enzyme-linked immunospot-based interferon-gamma release assay.",
        "pubDate": "2025-04-03T09:21:33Z",
        "displayTime": "2025-04-03T09:21:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/2d0681147ac2e04b8acb05e273314b5f",
          "originalWidth": 1440,
          "originalHeight": 809,
          "caption": "Revvity caters to a diverse clientele",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3jTbTFpcZA61siYonKCXAg--~B/aD04MDk7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/2d0681147ac2e04b8acb05e273314b5f.cf.webp",
              "width": 1440,
              "height": 809,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gl5dskle07dR7J1LnGrBZw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/2d0681147ac2e04b8acb05e273314b5f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/fda-revvity-tuberculosis-test/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-revvity-auto-pure-092133605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]